Biofarm S.A. (BVB:BIO)

Market Cap	859.24M
Revenue (ttm)	310.33M
Net Income (ttm)	86.10M
Shares Out	985.37M
EPS (ttm)	0.08
PE Ratio	10.98
Forward PE	n/a
Dividend	0.03 (3.56%)
Ex-Dividend Date	Aug 18, 2025

Volume	150,209
Average Volume	106,385
Open	0.8720
Previous Close	0.8720
Day's Range	0.8720 - 0.8920
52-Week Range	0.6200 - 0.8980
Beta	0.35
RSI	65.49
Earnings Date	Aug 14, 2025

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 373
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.